首页 >
法规速递
-
关于公开征求《药物上市申请临床评价技术指导原则（征求意见稿）》意见的通知-2025/9/29
2025-09-30查看详情 > -
Document: Applications for new human medicines under evaluation: November 2025-2025/11/5
2025-11-06查看详情 > -
Page: Antiviral medicines for pandemic influenza-2025/12/4
2025-12-05查看详情 > -
Document: Dates of 2026 Scientific Advice Working Party - Human (SAWP-H) meetings and submission deadlines for scientific advice, protocol assistance, qualification of novel methodologies and HTACG/EMA parallel Joint Scientific Consultation (JSC) requests
2026-01-14查看详情 > -
Document: Medicine shortage communication (MSC): Natpar (parathyroid hormone) (25, 50, 75 and 100 micrograms/dose powder and solvent for solution for injection)-2026/2/13
2026-02-14查看详情 > -
Page: Guidance on good manufacturing practice and good distribution practice: Questions and answers-2026/3/24
2026-03-25查看详情 > -
Document: List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment-2026/4/28
2026-04-29查看详情 > -
Document: Records of data processing activity regarding EMA Account Management System (public)-2026/6/9
2026-06-10查看详情 > -
关于公开征求《药物临床试验方案审评工作规范（征求意见稿）》意见的通知-2022/10/27
2022-11-14查看详情 > -
国家药监局关于发布化学仿制药参比制剂调整程序的公告（2023年第35号）-2023/03/24
2023-03-24查看详情 >
